论文部分内容阅读
抗乳腺癌新药罗格替米以１３名患有晚期乳腺癌并已绝经的妇女为对象，就氨鲁米特（１０００ｍｇ／ｄ加氢化可的松）与罗格替米（Ｒｏｇｌｅｔｉｍｉｄｅ２００，４００与８００ｍｇｂｉｄ）对外周芳构化的作用的影响进行比较性研究。虽然罗格替米产生剂量依赖的雌二醇抑制...
A new anti-breast cancer drug, roglegmitte, was administered to 13 women with advanced breast cancer and menopause and was evaluated for the combination of aminogluteth (1000 mg / day plus hydrocortisone) and rogletimide 200,400 800mgbid) on the effect of aromatization on peripherals was comparatively studied. Although rosiglitazone produces a dose-dependent inhibition of estradiol ...